随着或没有外部升降器进步的额头骨进步对先天性瘤的结果:一个回顾性比较研究
Marissa K Shoji1, Akshara R Legala2, Rolika Bansal1
1From the Division of Oculofacial Plastic and Reconstructive Surgery (M.K.S., R.B., N.D.E.J., S.C., C.Y.L., D.O.K., B.S.K.), Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California, USA.
American journal of ophthalmology
|September 24, 2025
概括
将额叶的推进与外部升降器的推进 (ELA) 结合起来,可显著改善带有低升降器功能的先天性阴病例中的眼升高. 这种综合方法提供了更好的结果,并降低了修订率与单独的额叶相比.
科学领域:
- 眼科医生 眼科 眼科
- 手术技巧 手术技巧
- 儿科眼科护理 儿科眼科护理
背景情况:
- 带有不良升降器功能的先天性阴,在实现足够的眼升高方面提出了手术挑战.
- 前额叶片的提升是一种常见的技术,但在严重的情况下,其有效性可能受到限制.
研究的目的:
- 为了比较单独的额叶进步结果与与外部升降器进步 (ELA) 结合的结果,使用双层技术来治疗与升降器功能差的先天性亡.
主要方法:
- 在76名患有严重先天性死和缺陷升降器功能的患者 (92个眼皮) 的回顾性比较队列研究中.
- 患者单独或与ELA (bilayer技术) 结合进行了额叶的提升.
- 主要结局是边际反射距离-1 (MRD1) 的变化;次要结局包括斜眼,对称性和不良事件.
主要成果:
- 这两种技术都显著改善了MRD1 (P < .001).
- 前额叶 + ELA 组显示显著更大的MRD1改善 (3.4 ± 1.2毫米对2.5 ± 1.6毫米,P = .002) 和更高的术后MRD1 (3.9 ± 0.8毫米对3.2 ± 1.2毫米,P = .004).
- 在ELA组中不需要修订,而在单独前额叶组中为7.6%;在两者中,尾仍然稳定.
结论:
- 使用双层技术与ELA结合的前额叶的推进是一种安全有效的外科手术策略,用于具有低升机功能的先天性亡.
- 这种综合方法提供了优越的眼升高,并优化了视觉轴的空隙.
- 它避免了对合成或自主悬浮材料的需求.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...